We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADSK icon
26
Autodesk
ADSK
$47.7B
$67.2M 0.63%
291,099
-6,015
-2% -$1.43M
PEP icon
27
PepsiCo
PEP
$191B
$67.1M 0.63%
484,111
+87,805
+22% +$11.9M
TSLA icon
28
Tesla
TSLA
$1.22T
$66M 0.62%
461,829
-81,636
-15% -$9.64M
ABT icon
29
Abbott
ABT
$182B
$65.4M 0.61%
600,770
+124,711
+26% +$12.7M
WM icon
30
Waste Management
WM
$95.5B
$64.6M 0.61%
570,411
+96,076
+20% +$10.6M
ALXN
31
DELISTED
Alexion Pharmaceuticals
ALXN
$64.4M 0.61%
563,072
-1,027
-0.2% -$111K
BIO icon
32
Bio-Rad Laboratories Class A
BIO
$8.47B
$63.5M 0.6%
123,252
+20,107
+19% +$10.2M
NKE icon
33
Nike
NKE
$62.5B
$62.8M 0.59%
500,384
-49,915
-9% -$5.36M
JNJ icon
34
Johnson & Johnson
JNJ
$641B
$62M 0.58%
416,161
+5,780
+1% +$855K
ABBV icon
35
AbbVie
ABBV
$454B
$58.3M 0.55%
665,808
+2,238
+0.3% +$211K
XLRN
36
DELISTED
Acceleron Pharma
XLRN
$56.9M 0.53%
505,380
+124,371
+33% +$12.4M
HOLX
37
DELISTED
Hologic
HOLX
$55.2M 0.52%
830,735
+157,737
+23% +$9.98M
ADBE icon
38
Adobe
ADBE
$94.5B
$55M 0.52%
112,095
-6,719
-6% -$3.13M
ROK icon
39
Rockwell Automation
ROK
$51.9B
$51.7M 0.49%
234,175
+37,145
+19% +$8.3M
UNH icon
40
UnitedHealth
UNH
$379B
$50.1M 0.47%
157,818
-37,523
-19% -$11.5M
BPMC
41
DELISTED
Blueprint Medicines
BPMC
$49.5M 0.47%
534,015
-344,629
-39% -$26.5M
PANW icon
42
Palo Alto Networks
PANW
$259B
$49.1M 0.46%
1,204,566
+444,426
+58% +$18.5M
JD icon
43
JD.com
JD
$41.8B
$48.5M 0.46%
624,344
-120,066
-16% -$8.34M
JPM icon
44
JPMorgan Chase
JPM
$947B
$47.4M 0.45%
492,391
-153,741
-24% -$15.1M
APD icon
45
Air Products & Chemicals
APD
$65.2B
$47.2M 0.44%
158,627
+9,860
+7% +$2.84M
ONC
46
BeOne Medicines Ltd
ONC
$33.8B
$47M 0.44%
164,197
-2,079
-1% -$489K
ADI icon
47
Analog Devices
ADI
$181B
$46.6M 0.44%
399,186
+40,994
+11% +$4.8M
UNP icon
48
Union Pacific
UNP
$178B
$46.6M 0.44%
236,614
+52,850
+29% +$9.82M
AVGO icon
49
Broadcom
AVGO
$1.82T
$45.6M 0.43%
1,251,520
-331,690
-21% -$11.1M
HD icon
50
Home Depot
HD
$335B
$44M 0.41%
158,462
+15,782
+11% +$4.27M
1
2
3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.